HomeCompareFMTM vs MRK

FMTM vs MRK: Dividend Comparison 2026

FMTM yields 0.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.7K in total portfolio value
10 years
FMTM
FMTM
● Live price
0.27%
Share price
$34.76
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.1K
Annual income
$27.87
Full FMTM calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FMTM vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFMTMMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FMTM + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FMTM pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FMTM
Annual income on $10K today (after 15% tax)
$23.27/yr
After 10yr DRIP, annual income (after tax)
$23.69/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,304.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FMTM + MRK for your $10,000?

FMTM: 50%MRK: 50%
100% MRK50/50100% FMTM
Portfolio after 10yr
$38.4K
Annual income
$4,913.00/yr
Blended yield
12.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FMTM
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FMTM buys
0
MRK buys
0
No recent congressional trades found for FMTM or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFMTMMRK
Forward yield0.27%2.76%
Annual dividend / share$0.10$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20.1K$56.8K
Annual income after 10y$27.87$9,798.13
Total dividends collected$276.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FMTM vs MRK ($10,000, DRIP)

YearFMTM PortfolioFMTM Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,727$27.38$11,206$366.19$479.00MRK
2$11,506$27.45$12,650$502.35$1.1KMRK
3$12,339$27.51$14,407$694.19$2.1KMRK
4$13,230$27.57$16,585$967.82$3.4KMRK
5$14,184$27.63$19,342$1,363.89$5.2KMRK
6$15,204$27.68$22,913$1,947.19$7.7KMRK
7$16,296$27.73$27,662$2,823.89$11.4KMRK
8$17,465$27.78$34,159$4,173.35$16.7KMRK
9$18,715$27.83$43,337$6,308.80$24.6KMRK
10$20,053$27.87$56,776$9,798.13$36.7KMRK

FMTM vs MRK: Complete Analysis 2026

FMTMStock

FMTM seeks long-term capital appreciation by investing in equity securities determined to have positive momentum characteristics. The fund employs a multi-step, quantitative, rules-based methodology to identify securities with the highest perceived relative momentum. The starting universe consists of US equities that meet market-cap and liquidity requirements. The fund then uses quality screens based on financial statement metrics to remove companies with low returns on assets or high debt-to-equity. The next quantitative screen uses daily share price data to identify and rank companies exhibiting persistent upward share price momentum. The fund finally selects 30 to 50 large- and mid-cap securities. The actively managed fund repeats this process on a monthly basis.

Full FMTM Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FMTM vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FMTM vs SCHDFMTM vs JEPIFMTM vs OFMTM vs KOFMTM vs MAINFMTM vs JNJFMTM vs ABBVFMTM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.